Published January 15, 2020
| Version v1
Journal article
Open
The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
- 1. "Toma Ciorba" Clinical Hospital of Infectious Diseases
- 2. Department of Infectious Tropical Diseases and Medical Parasitology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau
Description
Viral hepatitis C (HCV) is a significant global health problem. The risk of developing chronic HCV is up to 80% of patients, of whom 10-20% can develop liver cir-rhosis or hepatocellular carcinoma which can lead to death. Treatment with direct-acting antiviral agents (DAAs) contributes to a sustained virological response (SVR) in 97-99% of cases.
Files
4-11_7.pdf
Files
(581.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:e579a9ec59c06e1c0f98c475b1827eb4
|
581.2 kB | Preview Download |